Reporting Manager
Madison Avenue International LP
Symbol
INDV
Shares outstanding
125,610,040 shares
Disclosed Ownership
6,280,502 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:57:13 UTC
Date of event
31 Dec 2025
Previous filing
18 Mar 2025

Quoteable Key Fact

"Madison Avenue Partners, LP disclosed 5% ownership in Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV) on 31 Dec 2025."

Quick Takeaways

  • Madison Avenue Partners, LP filed SCHEDULE 13G/A for Indivior Pharmaceuticals, Inc. Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") (INDV).
  • Disclosed ownership: 5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 18 Mar 2025.
  • Current filing was accepted on 17 Feb 2026, 16:57.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Madison Avenue International LP 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP
Madison Avenue Partners, LP 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP
EMAI Management, LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Managing Member
Madison Avenue GP, LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Manager
Caraway Jackson Investments LLC 5% 6,280,502 0 6,280,502 /s/ Eli Samaha Eli Samaha, as Member
Eli Samaha 5% 6,280,502 0 6,280,502 /s/ Eli Samaha ELI SAMAHA
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .